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Background: This study was designed to determine if electroacupuncture (EA) preconditioning improves tissue
outcome and functional outcome following experimentally induced cerebral ischemia in mice. In addition, we
investigated whether the expression of brain-derived neurotrophic factor (BDNF) and stromal cell derived factor-1α
(SDF-1α) and infarct volume were related with improvement in neurological and motor function by interventions in
this study.
Methods: After treatment with EA at the acupoints ‘Baihui (GV20)’ and ‘Dazhui (GV14)’ for 20 min, BDNF was
assessed in the cortical tissues based on Western blot and the SDF-1α and vascular endothelial growth factor
(VEGF) levels in the plasma determined by ELISA. To assess the protective effects of EA against ischemic injury, the
mice received once a day 20 min EA preconditioning for three days prior to the ischemic event. Focal cerebral
ischemia was then induced by photothrombotic cortical ischemia. Infarct volumes, neurobehavioral deficit and
motor deficit were evaluated 24 h after focal cerebral ischemia.
Results: The expression of BDNF protein increased significantly from 6 h, reaching a plateau at 12 h after the end
of EA treatment in the cerebral cortex. Furthermore, SDF-1α, not VEGF, increased singnificantly from 12 h to 48 h
after EA stimulation in the plasma. Moreover, EA preconditioning reduced the infarct volume by 43.5% when
compared to control mice at 24 h after photothrombotic cortical ischemia. Consistent with a smaller infarct size, EA
preconditioning showed prominent improvement of neurological function and motor function such as
vestibule-motor function, sensori-motor function and asymmetric forelimb use. The expression of BDNF colocalized
within neurons and SDF-1α colocalized within the cerebral vascular endothelium was observed throughout the
ischemic cortex by EA.
Conclusions: Pretreatment with EA increased the production of BDNF and SDF-1α, which elicited protective effects
against focal cerebral ischemia. These results suggest a novel mechanism of EA pretreatment-induced tolerance
against cerebral ischemic injury.
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Despite decades of intense research, the treatment of
strokes by anticoagulation, thrombolysis and neuropro-
tection have not been found to fully improve stroke
patients. Electroacupuncture (EA), a traditional therapy,
has been recommended as a complementary therapy for
pain relief [1] and stroke rehabilitation [2]. Several stu-
dies investigating the effectiveness of EA with cerebral
ischemia have been conducted and beneficial outcomes
were observed in experimental animals [3-8]. Therefore,
EA presumably improves the outcome of stroke patients;
however, the cellular mechanisms underlying this im-
provement remain elusive.
In the pretreatment effect, a brief exposure to sub-
lethal or noninjurious stimuli increases resistance to
subsequent prolonged and lethal damage [9]. EA pre-
treatment has recently been shown to induce ischemic
tolerance in a fashion mimicking the ischemia pretreat-
ment [10,11]. Since EA is economical, easily conducted,
and has fewer negative side effects than other prevention
methods (e.g., pharmacological, ischemic, etc.), it should
be valuable and advantageous to preventing ischemic
cerebrovascular disease, especially in patients at high
risk of ischemic injury. Many studies have shown that
protective mechanisms of EA pretreatment may involve
a series of regulatory molecular pathways including
enhanced antioxidant activity [8], regulation of the endo-
cannabinoid system [12], and involvement of the postre-
ceptor signaling pathway [13]. However, the mechanism
is not fully understood and more evidence is needed for
pretreatment with EA to be accepted clinically.
Neurotrophic factors not only contribute to protection in
the acute phase and neurogenesis in the chronic phase after
cerebral ischemia, but also provide preconditioning-induced
ischemic tolerance [14]. Among neurotrophic factors, brain-
derived neurotrophic factor (BDNF) and stromal cell derived
factor-1α (SDF-1α) are thought to be potent candidates in
the recovery from cerebral ischemia [15-17]. However, little
is known about the involvement of BDNF and SDF-1α in
EA preconditioning in ischemic brains.
Therefore, the present study was conducted to investigate
whether EA preconditioning at the Baihui (GV20) and Dazhui
(GV14) acupoints improves tissue outcome and func-
tional outcome following experimentally induced cere-
bral ischemia in mice. Furthermore, we investigated
whether the expression of BDNF and SDF-1α and in-




Male mice (C57BL/6J, 20–25 g) were housed under diur-
nal lighting conditions and allowed food and tap water ad
libitum. This study was carried out in strict accordancewith the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Pusan National
University Institutional Animal Care and Use Committee
(Permit Number: PNU-2011-000420). Anesthesia was
achieved by face mask-delivered isoflurane (2% induction
and 1.5% maintenance, in 80% N2O and 20% O2).
Electroacupuncture stimulation
Animals were anesthetized with isoflurane to avoid re-
straint stress. The transpositional method was used to
determine the acupoints in mice, which locates the ve-
terinary acupoints by transforming human acupoints
onto animal anatomy [18]. The acupoint ‘Baihui (GV20)’,
which is located at the right midpoint of the parietal
bone, and ‘Dazhui (GV14)’, which is located on the pos-
terior midline and in the depression below the spinous
process of the seventh cervical vertebra, were stimulated
as standard criteria in mouse (Figure 1A). To accomplish
this acupuncture needles (0.18 × 30 mm) were inserted
into the GV20 and GV14 to the depth of approximately
3 mm, after which the acupoints were stimulated at an
intensity of 1 mA and a frequency of 2 Hz for 20 min
using Grass S88 electro stimulator (Grass Instrument
Co., West Warwick, RI). The intensity was maintained
just below the level that induced visible muscle contrac-
tion. The control groups received the same electrical
stimulation at non-acupuncture points. To assess the
protective effects of EA on ischemic injury, the mice
received once a day 20 min EA preconditioning for three
days prior to the ischemic event (Figure 1C).
Western blotting
Each mouse was deeply anesthetized with thiopental so-
dium at 6, 12, 24 and 48 h after EA stimulation (Figure 1B),
subsequently perfused transcardially with cold PBS and
brain cortex was collected. Immunoblot analysis was
performed with BDNF antibodies (Millipore, Temecula,
CA) followed by incubation with secondary antibody
conjugated with horseradish peroxidase. The intensity
of chemiluminescence was measured using an Image-
Quant LAS 4000 apparatus (GE Healthcare Life Sciences,
Uppsala, Sweden).
Measurement of SDF-1α and VEGF in the plasma
To determine the effects of EA treatment on SDF-1α
and vascular endothelial growth factor (VEGF) produc-
tion, blood sample was collected through cardiac punc-
ture at 6, 12, 24 and 48 h after the end of EA treatment
(Figure 1B). Blood sample was taken from the heart, pre-
ferably from the ventricle slowly to avoid collapsing of
heart. The plasma was separated and kept at −80°C until
assay. The amount of SDF-1α and VEGF from plasma
was determined using a commercially available ELISA
Figure 1 Summary of experimental protocols. (A) Mouse schematic showing the location of the acupuncture points used in the study. GV20
stands for ‘Baihui’, which is located at the right midpoint of the parietal bone, GV14 stands for ‘Dazhui’, which is located on the posterior midline
and in the depression below the spinous process of the seventh cervical vertebra. (B) The time line showing the chronological events of western
blotting and ELISA studies. The brain tissue and blood were collected at 6, 12, 24 and 48 h after the end of EA treatment. (C) The time line
showing the chronological events of the protective effects of EA on ischemic injury. The mice received once a day 20 min EA preconditioning for
three days prior to the ischemic event, then focal cerebral ischemia was induced by photothrombotic cortical ischemia. Infarct volumes,
neurobehavioral deficit and motor deficit were evaluated 24 h after focal cerebral ischemia.
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Systems, Minneapolis, MN). The color intensity was
determined using a SpectraMax190 microplate reader
(Molecular Devices, Sunnyvale, CA).
Focal cerebral ischemia
Focal cerebral ischemia was induced by a photothrom-
botic cortical ischemia model [19]. Rose Bengal (Sigma-
Aldrich; 0.1 ml of a 10 mg/ml solution in sterile saline)
was injected intraperitoneally 5 min before illumination.
After mice were placed in a stereotaxic frame, a midline
scalp was incised, pericranial tissues were dissected, and
the bregma and lambda points were identified. A fiber
optic bundle of a KL1500 LCD cold light source (Carl
Zeiss, Jena, Germany) with a 4 mm aperture was cen-
tered using a micromanipulator 2 mm laterally from the
bregma. The brain was illuminated through the intact
skull for 15 min, after which the surgical wound was
sutured and mice were allowed to recover from
anesthesia. The brains were removed 24 h after ischemiainsults. The cerebral infarct size was then determined on
2,3,5-triphenyltetrazolium chloride (TTC)-stained, 2-
mm-thick brain sections. Infarction areas were quanti-
fied with iSolution full image analysis software (Image
& Microscope Technology, Vancouver, Canada). To ac-
count for and eliminate the effects of swelling/edema,
the infarction volume was calculated using an indirect
measurement in which the volumes of each section
were summed according to the following formula:
contralateral hemisphere (mm3) - undamaged ipsilateral
hemisphere (mm3).
Neurological score
Neurological deficit was scored in each mouse at 24 h
after the ischemic insult in a blinded fashion according to
the following graded scoring system: 0 = no deficit; 1 =
forelimb weakness and torso turning to the ipsilateral side
when held by tail; 2 = circling to the affected side; 3 = un-
able to bear weight on the affected side; and 4 = no spon-
taneous locomotor activity or barrel rolling [20].
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Vestibulo-motor function was assessed using a wire-grip
test 24 h after cerebral ischemia [21]. Briefly, mice were
placed on a metal wire (45 cm long) suspended 45 cm
above protective padding and allowed to traverse the wire
for 60 sec. The latency for which a mouse remained on
the wire within a 60-sec interval was measured, and the
wire grip score was quantified using the 5-point scale.
Corner test
This test detects integrated sensori-motor function as it
involves both stimulation of the vibrissae (sensory/neglect)
and rearing (motor response) as previously described [22].
The mouse was placed between two cardboard pieces,
each with a dimension of 30 × 20 × 1 cm3. The two boards
were gradually moved closer to the mouse from both sides
to encourage it to enter into a corner of 30° with a small
opening along the joint between the two boards. When
the mouse entered into the deep the part of the corner,
both sides of the vibrissae were stimulated together by the
two boards. The mouse then reared forward and upward,
after which it turned back to face the open end. Twenty
trials were performed for each mouse and the percentage
of right turns was calculated.
Cylinder test
The cylinder test was adapted for use in mice to assess
forelimb use and rotation asymmetry [23]. Briefly, the
mouse was placed in a transparent cylinder 9-cm in dia-
meter and 15 cm tall. After the mouse was put into the cy-
linder, forelimb use of the first contact against the wall
after rearing and during lateral exploration was recorded.Figure 2 Temporal production of BDNF in the brain tissues and SDF-1
western blot of BDNF protein in the cerebral cortex at 0 h (control), 6 h, 12
shows densitometric analysis of the western blot of BDNF. Relative abunda
levels in mice at 0 h (control), 6 h, 12 h, 24 h, and 48 h after the end of EA
mean ± SEM. *, P<0.05 and **, P<0.01 vs. control. Numbers of mice used foThe final score = (nonimpaired forelimb movement -
impaired forelimb movement)/(nonimpaired forelimb
movement + impaired forelimb movement + both move-
ment). This test evaluates forelimb use asymmetry for
weight shifting during vertical exploration and provides
high inter-rater reliability with even inexperienced raters.
Immunohistochemistry and immunofluorescence
Twenty four hours after cerebral ischemia, mice deeply
anesthetized with thiopental sodium were perfused
transcardially with cold PBS followed by 4% paraformal-
dehyde for fixation. The brain of each mouse was then
removed and further fixed for 24 h in 4% paraformalde-
hyde at 4°C followed by cryoprotection in 20% sucrose
for 72 h at 4°C. The frozen brains were cut at a thickness
of 14 μm using a Leica CM 3050 cryostat (Leica Micro-
systes, Wetzlar, Germany). For immunohistochemistry,
the sections were stained with antibody against BDNF
(Millipore) or SDF-1α (R&D Systems). Following add-
itional incubation with biotinylated secondary antibody,
samples were incubated in ABC reagent (Vector Labora-
tories, Burlingame, CA). All reactions were visualized
by development in 3,3’ diaminobenzidine substrates
(Vector Laboratories), and all samples were visualized
using a light microscope (Carl Zeiss, Jena, Germany).
The immunoreaction products were quantified using
the iSolution full image analysis software. In double-
fluorescence staining, sections were stained with anti-
NeuN (Chemicon, Temecula, CA) or anti-CD31 antibody
(BD Biosciences, Franklin Lakes, NJ), after which they
were treated with FITC-conjugated secondary antibody to
detect NeuN or CD31, and subsequently with anti-BDNFα and VEGF levels in the plasma following EA. (A) Representative
h, 24 h, and 48 h after the end of EA stimulation. The lower panel
nce of BDNF compared with β-actin. (B) Plasma SDF-1α and VEGF
stimulation were analyzed by ELISA. The results are expressed as the
r BDNF, SDF-1α and VEGF measurement are shown on each bar.
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red-conjugated secondary antibody to detect BDNF or
SDF-1α. Fluorescent-stained sections were analyzed by
Axio Imager fluorescence microscopy (Carl Zeiss,
Jena, Germany).
Data analysis
The data are expressed as mean ± standard error of
mean (SEM). BDNF, SDF-1α and VEGF levels after EA
stimulation was analyzed by one-way analysis of variance
(ANOVA) and control vs. EA group was compared by
unpaired t-test. The differences were considered statisti-
cally significant, when the two-tailed p values were less
than 0.05. Statistical analysis was performed using Sig-
maPlot 11.2 (Systat Software Inc, San Jose, CA).
Results
Effect of EA on BDNF, SDF-1α and VEGF production
Using a time course of EA treatment, BDNF was
assessed in the brain tissues from identical cortical areasFigure 3 Effect of EA preconditioning on tissue and functional outcom
infarction stained with 2,3,5-triphenyltetrazolium chloride. The red area is h
(Con). (B) Neurological deficit and motor deficit were assessed 24 h after is
vestibule-motor function by a wire grip test, sensori-motor function by a co
test. A regression line showed the relationship between tissue injury (infarc
corner test and cylinder test). Results are expressed as mean ± SEM for tweby Western blot. The expression of BDNF protein sig-
nificantly increased from 6 h, reaching a plateau at 12 h
after the end of EA treatment (216.32±38.97%, P<0.05
vs. control). After 24 h, BDNF protein levels began to
decrease, returning to near the control level by 48 h
(Figure 2A). Figure 2B illustrates the time course of
SDF-1α and VEGF levels in the plasma at 6, 12, 24 and
48 h after EA stimulation. Treatment with EA gradually
increased the plasma content of SDF-1α from 12 h to
48 h (3.18±0.15 ng/ml vs. 2.15±0.17 ng/ml, 48 h and
control respectively, P<0.01). However, there was no dif-
ference in VEGF production in the plasma at 6, 12, 24
and 48 h after the end of EA treatment (Figure 2B).
Effect of EA preconditioning on tissue outcome and
functional outcome
To assess the protective effects of EA on ischemic injury,
the mice received once a day 20 min EA preconditioning
for three days prior to the ischemic event. EA precondi-
tioning reduced the infarct volume by 43.5% whene. (A) Representative photographs of coronal brain sections following
ealthy tissue and the white area is infarct tissue. *, P<0.05 vs. control
chemia. Neurological function was assessed by neurological score,
rner test and asymmetry forelimb use for weight shifting by a cylinder
t volume) and functional outcome (neurological score, wire grip test,
lve mice in each group. *, P<0.05 and **, P<0.01 vs. control (Con).
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photothrombotic cortical ischemia (Figure 3A). Consist-
ent with a smaller infarct size, EA preconditioning
showed prominent improvement of neurological func-
tion and motor functions (Figure 3B).
Effect of EA preconditioning on BDNF and SDF-1α
expression in ischemic brain
To explore the underlying mechanisms of EA precondi-
tioning on focal cerebral ischemia, we investigated
BDNF and SDF-1α expression in the ischemic cortex. A
large number of BDNF- and SDF-1α-positive cells in the
ischemic cortex were observed in the EA group, whereas
only a small amount of BDNF- and SDF-1α-positive cells
were observed in the control group (Figure 4A and
Figure 5A). Double immunofluorescence staining was
performed to determine the relationship between BDNF
and neuronal cells, or BDNF and endothelial cells. Al-
most all BDNF-positive cells (red) colocalized with the
neuronal cell marker NeuN (green) (Figure 4B), whereas
few BDNF-positive cells coexpressing the endothelial
phenotype of CD31-positive cells were observed (dataFigure 4 Effect of EA preconditioning on BDNF expression in ischemi
photographs showed BDNF-positive cell expression 24 h after occlusion in
rectangle represents the imaging field. Quantification of BDNF-positive cell
expressed as mean ± SEM for three mice in each group. *, P<0.05 vs. contr
BDNF (red) and NeuN (neuronal marker, green) in EA-preconditioned ische
neurons after ischemic injury. Scale bar = 100 μm.not shown). However, double immunofluorescence for
SDF-1α and CD31 demonstrated that the SDF-1α was
primarily localized in endothelium in the cerebral cortex
(Figure 5B).
Discussion
The present study demonstrated that tolerance to focal
cerebral ischemia induced by EA pretreatment is mediated
by BDNF and SDF-1α. Our results showed that pretreat-
ment with EA at Baihui (GV20) and Dazhui (GV14) for
20 min increased the brain tissue content of BDNF and
upregulated the production of SDF-1α in the plasma.
Moreover, EA preconditioning reduced infarct volume by
43.5% when compared to control mice 24 h after photo-
thrombotic cortical ischemia. Consistent with a smaller
infarct size, EA preconditioning showed prominent im-
provement of neurological function and motor function
such as vestibule-motor function, sensori-motor function
and asymmetry forelimb use. The expression of BDNF,
colocalized within neurons, and SDF-1α, colocalized
within the cerebral vascular endothelium, was observed
throughout the ischemic cortex following EA. Thesec brain. (A) Representative immunohistochemical staining
the ischemic cortex of mice that received control or EA. The blue
s is expressed as the % change of the control. The results are
ol (Con). (B) Representative double immunofluorescence staining for
mic brain. EA-induced BDNF expression was colocalized with the
Figure 5 Effect of EA preconditioning on SDF-1α expression in ischemic brain. (A) Representative immunohistochemical staining showed
SDF-1α-positive cell expression 24 h after occlusion in the ischemic cortex of mice that received control or EA. The blue rectangle represents the
imaging field. Quantification of SDF-1α-positive cells is expressed as the % change of the control. The results are expressed as mean ± SEM for
three mice in each group. *, P<0.05 vs. control (Con). (B) Representative double immunofluorescence staining for SDF-1α (red) and CD31
(endothelial cell marker, green) in EA-preconditioned ischemic brain. EA-induced SDF-1α was colocalized with the endothelium after ischemic
injury. Scale bar = 100 μm.
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that elicited neuroprotective effects induced by EA pre-
conditioning against focal cerebral ischemia.
Anticoagulation, thrombolysis and cellular protection
have not been shown to fully improve stroke patients.
EA is a novel therapy based on traditional acupuncture
combined with modern electrotherapy. Clinically, acu-
puncture has shown significant therapeutic benefits for
stroke patients [1,2,24,25]. A large number of animal
studies have shown that EA could reduce neural apop-
tosis, promote cell proliferation, increase cerebral blood
flow (CBF), and improve neurological function after
stroke [4-7]. However, the precise mechanism of EA
function remains controversial. In addition, the type of
stroke, its severity and the interval after the stroke and
pretreatment might also significantly influence the
results of EA studies [26].
Preconditioning as a potent endogenous protective re-
sponse, activates several endogenous signaling pathways
that result in tolerance against ischemia [27]. In recent
years, numerous studies have shown that EA also have
pretreatment effects, including ischemic tolerance aswell [10,11]. Since EA is economical, easily performed,
and has few negative side effects, it is clinically applic-
able for prevention, and not just treatment of ischemic
cerebral disease. Our study demonstrated that, similar to
the ischemic tolerance induced by ischemic precondi-
tioning, repeated EA pretreatment at Baihui (GV20) and
Dazhui (GV14) for 20 min a day for three days before le-
thal ischemic insult could reduce infarct volumes and
improve neurological function and motor function 24 h
after occlusion. These findings indicate that EA pretreat-
ment could induce tolerance to cerebral ischemic insult.
EA has been reported to increase neurotrophic factors
such as insulin-like growth factor 1, basic fibroblast
growth factor, glial derived neurotrophic factor or recep-
tors, NMDA NR1 and TRPM7 [13,28-30]. BDNF, SDF-
1α and VEGF are hypoxia-inducible factor (HIF)-1 target
proteins, which have been implicated in mediating neu-
roprotection after hypoxic preconditioning [31,32].
BDNF, SDF-1α and VEGF can affect both neuronal and
vascular function in the ischemic brain. BDNF was ori-
ginally discovered through its neuronal effects and then
later found to also have vascular effects, whereas SDF-
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angiogenic effects and then later found to also have neu-
roprotective activity [33]. BDNF is a potent growth fac-
tor involved in recovery following cerebral ischemia
[15,16]. Altered BDNF plasma levels or association of
BDNF genotypes indicate that this growth factor may be
involved in the physiological response to stroke in
humans [15]. SDF-1α, a CXC chemokine produced by
bone marrow stromal cells, a potent chemo-attractant
for hematopoietic stem cells, is constitutively expressed
by all tissues [34]. Stumm et al. demonstrated that focal
cerebral ischemia causes an increase in endothelial SDF-
1α expression in regions adjacent to the infarcted area
[35]. Recently, intracerebral administration of SDF-1α
was reported to induce neuroprotection against neuro-
toxic insult, and induce increased bone marrow-derived
cell targeting of the ischemic brain, thereby reducing the
volume of cerebral infraction and improving neural plas-
ticity [17]. VEGF is an angiogenic peptide that also
exerts a large number of diverse neuronal effects in the
central nervous system [36]. For these reasons, BDNF,
SDF-1α and VEGF are potent candidates in ischemic
preconditioning; however, little is known about the in-
volvement of them in EA preconditioning in ischemic
brains. Therefore, we examined whether BDNF, SDF-1α
and VEGF were involved in neuroprotective effects of
EA preconditioning in focal cerebral ischemia. We found
that EA preconditioning increased the brain tissue con-
tent of BDNF and upregulated the production of SDF-1α
in the plasma. In addition, a large number of BDNF-
and SDF-1α-positive cells in the ischemic cortex were
observed in the EA group. Moreover, the present im-
munofluorescence data showed that BDNF immunoreac-
tivities were colocalized with NeuN immunoreactivities
and SDF-1α immunoreactivities with CD31 immunor-
eactivities, indicating that the effect of EA pretreatment
on BDNF expression was neuron-specific and SDF-1α
was vessel-specific in the ischemic cortex. These current
results strongly suggest that upregulation of neuronal
BDNF and vascular SDF-1α after EA pretreatment might
be an important protective mechanism of tolerance
against ischemia. Interestingly, SDF-1α production was
upregulated in a time-dependent manner following EA
stimulation, while VEGF remained unchanged after EA
pretreatment in the plasma. A few studies have shown
that VEGF production was increased by EA [37]. These
different results might be due to differences in the seve-
rity of cerebral ischemia or the use of different acupoints
in this and previous studies.
Conclusions
The present study showed that EA stimulation at the
GV20 and GV14 acupoints before focal cerebral ische-
mia has neuroprotective potential mediated, at least inpart, by increased BDNF and SDF-1α expression. The
present findings suggest a novel mechanism of EA
pretreatment-induced tolerance against cerebral ische-
mic injury in mice.
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